News about Safety

Sarepta Pauses Shipments of Duchenne Gene Therapy Elevidys Amid FDA Safety Review

Sarepta Therapeutics has announced a voluntary and temporary suspension of all US shipments of its Duchenne muscular dystrophy (DMD) gene therapy, ELEVIDYS (delandistrogene moxeparvovec), following the FDA’s distribution suspension request last week.

Safety | 24/07/2025 | By Dineshwori |  561

Custom Portable Sampling Isolator Improves Safety of Pharmaceutical Manufacturing

Custom Portable Sampling Isolator Improves Safety of Pharmaceutical Manufacturing

Safety | 18/08/2023 | By Sudeep Soparkar |  1177

Lupin recalls 16,056 bottles of Rifampin capsules to treat TB

Manufacturing issues were cited

Safety | 23/01/2023 | By Sudeep Soparkar |  1382

Laurus Labs' AP manufacturing block under fire

Four employees succumbs

Safety | 03/01/2023 | By Sudeep Soparkar |  1494

Freudenberg accomplishes ISO 14001 accreditation for its 11 overall destinations

Freudenberg Medical has accomplished ISO 14001 confirmation for every one of the 11 locales in the United States, Costa Rica, Germany, Ireland, and China. Meaning, all Freudenberg Medical activities overall satisfy the most noteworthy guidelines for ecological administration.

Safety | 13/04/2022 | By Sudeep Soparkar |  1318

Generic Pradaxa Capsules from Alembic Pharma given tentative approval by the US FDA

Alembic Pharmaceuticals Limited has gotten speculative endorsement from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for dabigatran etexilate cases, 75 mg, 110 mg, and 150 mg.

Safety | 08/04/2022 | By Sudeep Soparkar |  1434

COVID medicines medical devices: parliamentary panel for framing price control regime

A Parliamentary panel has recommended framing a new price control regime specific for medicines and medical devices for COVID-19 management and put them under price control with no annual increase in prices allowed till the pandemic is entirely over in the country

Safety | 22/03/2022 | By Darshana |  865

A Synopsis Of Themis Medicare Viralex

Mumbai-based pharmaceutical company Themis Medicare?s anti-viral drug Viralex has received Drugs Controller General of India?s (DCGI) approval, the company informed the stock exchange on Monday

Safety | 21/03/2022 | By Darshana |  787

Second R&D Center Of Boston Scientific Corporation Inaugurated In Pune

The second Research and Development Center is launched by the Boston Scientific Corporation in Pune. The major goal of this move is to make capital out of India?s expertise in R&D and to provide manifold opportunities for engineers and front-runners in the country

Safety | 16/03/2022 | By Darshana |  1719

First reference lab in Kolkata launched by Lupin

The new Reference Laboratory at Kolkata has capabilities to conduct a broad spectrum of routine and specialized tests in the fields of molecular diagnostics, cytogenetics, flow cytometry, histopathology, cytology, microbiology, serology, haematology, immunology and routine biochemistry

Safety | 11/03/2022 | By Darshana |  963